About
Partnering
Responsibility
People and Culture
News
Contact
Change Language

News

Refine by category
Refine by year
- 2020
- 2019
- 2018
- Archive

Press Releases —

ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million

01 Apr 2020
Learn more
Press Releases —

ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange

27 Mar 2020
Learn more
Press Releases —

ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results

25 Mar 2020
Learn more
Industry Related —

UPDATE ON COVID-19 VIRUS

18 Mar 2020
Learn more
Press Releases —

ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.

16 Mar 2020
Learn more
Press Releases —

ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results

11 Mar 2020
Learn more
Press Releases —

ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange

10 Mar 2020
Learn more
Press Releases —

ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million

06 Mar 2020
Learn more

Featured News

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

07 Aug 2019
Learn more
Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors

17 Jun 2019
Learn more
ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

04 Jan 2019
Learn more

About
Responsibility
People and Culture
News
Contact

Terms and Conditions
Privacy Policy
Recruitment Scams
Information Sources

Copyright 2020 Abcur English®. All Rights Reserved